TrialEuropean journal of clinical pharmacology2012

Population pharmacokinetic and exposure-response analysis of nilotinib in patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase.

Richard A Larson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.